Beam Therapeutics Presents Preclinical Data for Complementary Base Editing Approaches for Hemoglobinopathies at ASH 2019
HPFH program achieves in vivo proof of concept of long term engraftment with >90% base editing maintained after 16 weeks Makassar program demonstrates…
Read More